Why the study?
The prognostic significance of detecting LV systolic dysfunction during family screening programmes in relatives of probands affected by DCM and NDLVC remained unclear.
Does the detection of left ventricular systolic dysfunction through family screening programmes improve outcomes in first-degree relatives of probands with DCM/NDLVC?
Does the detection of left ventricular systolic dysfunction through family screening programmes improve outcomes in first-degree relatives of probands with DCM/NDLVC?
Detecting left ventricular systolic dysfunction through family screening programs in relatives of DCM/NDLVC probands is associated with a significantly better long-term prognosis compared to non-screened detection.
Answers are grounded in this paper and cite their sources.
Detection of LV systolic dysfunction during family screening was associated with higher adverse event risk; leaves open optimal screening frequency and management before practice change.
AIMS: The prognostic significance of detecting left ventricular (LV) systolic dysfunction during family screening programmes (FSPs) in relatives of probands affected by dilated (DCM) and non-dilated left ventricular (NDLVC) cardiomyopathies remain unclear. This study sought to evaluate the prognostic role of LV systolic dysfunction detection in relatives of DCM/NDLVC probands and to define the most accurate FSP. METHODS AND RESULTS: Baseline and follow-up data of first-degree relatives of probands affected by DCM/NDLVC were collected. The primary outcome was all-cause death and heart transplantation. Secondary heart failure (HF) and arrhythmic outcomes were also included. A total of 492 first degree relatives were enrolled. During a median follow-up of 110 months (interquartile range 57-188 months), only subjects that previously developed LV systolic dysfunction had primary outcomes (19 vs. 0, p < 0.001) and secondary outcomes (HF: 12 vs. 0, p = 0.005; arrhythmic: 30 vs. 0, p < 0.001). Subjects with LV systolic dysfunction detected by FSP showed lower rate of primary outcomes (FSP: n = 19 [14%]; no-FSP: n = 40 [37%]; p < 0.001) and secondary arrhythmic outcomes (FSP: n = 18 [13%]; no-FSP: n = 41 [38%]; p < 0.001). In this setting, family history of arrhythmia and being carrier of a pathogenic/likely pathogenic variant are the main risk factors for LV systolic dysfunction, while LV global longitudinal strain (LV-GLS) and Holter electrocardiogram (ECG) showed a relevant role in terms of prediction of LV systolic dysfunction and outcomes. CONCLUSIONS: Relatives of DCM/NDLVC probands who developed LV systolic dysfunction during a long follow-up had a significant increased risk of major adverse cardiovascular outcomes. However, LV systolic dysfunction detected by FSP showed a better prognosis. In this context, genetics, Holter ECG and LV-GLS demonstrated their functional role for disease and event prediction.
No takes yet. Share an insight, caveat, or question.
Mestre et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: